Tower Research Capital (TRC)’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$25K Buy
27,538
+4,232
+18% +$3.84K ﹤0.01% 3538
2025
Q1
$10.5K Sell
23,306
-1,624
-7% -$733 ﹤0.01% 3629
2024
Q4
$12.5K Buy
24,930
+12,540
+101% +$6.31K ﹤0.01% 3610
2024
Q3
$11.2K Sell
12,390
-18,787
-60% -$17K ﹤0.01% 3681
2024
Q2
$31.1K Buy
31,177
+30,205
+3,108% +$30.1K ﹤0.01% 3461
2024
Q1
$1.44K Sell
972
-7,335
-88% -$10.9K ﹤0.01% 5265
2023
Q4
$9.06K Sell
8,307
-2,030
-20% -$2.21K ﹤0.01% 4442
2023
Q3
$12.2K Buy
10,337
+2,361
+30% +$2.79K ﹤0.01% 3919
2023
Q2
$11.2K Sell
7,976
-1,992
-20% -$2.81K ﹤0.01% 3975
2023
Q1
$15K Sell
9,968
-1,376
-12% -$2.07K ﹤0.01% 3794
2022
Q4
$13K Buy
11,344
+11,042
+3,656% +$12.7K ﹤0.01% 3617
2022
Q3
$0 Buy
302
+100
+50% ﹤0.01% 6305
2022
Q2
$0 Sell
202
-7,689
-97% ﹤0.01% 6325
2022
Q1
$12K Buy
7,891
+83
+1% +$126 ﹤0.01% 4068
2021
Q4
$19K Buy
7,808
+4,161
+114% +$10.1K ﹤0.01% 3727
2021
Q3
$9K Sell
3,647
-4,968
-58% -$12.3K ﹤0.01% 4448
2021
Q2
$25K Buy
8,615
+8,415
+4,208% +$24.4K ﹤0.01% 3679
2021
Q1
$0 Buy
+200
New ﹤0.01% 5567
2020
Q4
Sell
-15,325
Closed -$14K 5291
2020
Q3
$14K Sell
15,325
-25,924
-63% -$23.7K ﹤0.01% 3965
2020
Q2
$36K Buy
+41,249
New +$36K ﹤0.01% 3307
2019
Q1
Sell
-22,789
Closed -$21K 4063
2018
Q4
$21K Buy
22,789
+22,755
+66,926% +$21K ﹤0.01% 1902
2018
Q3
$0 Sell
34
-21,934
-100% ﹤0.01% 4029
2018
Q2
$39K Buy
+21,968
New +$39K ﹤0.01% 1995
2018
Q1
Sell
-6,274
Closed -$12K 3608
2017
Q4
$12K Sell
6,274
-4,042
-39% -$7.73K ﹤0.01% 2439
2017
Q3
$26K Buy
+10,316
New +$26K ﹤0.01% 2551
2017
Q2
Sell
-23
Closed 3165
2017
Q1
$0 Sell
23
-2,450
-99% ﹤0.01% 3528
2016
Q4
$8K Buy
+2,473
New +$8K ﹤0.01% 2777
2015
Q3
Sell
-6,766
Closed -$20K 4442
2015
Q2
$20K Buy
6,766
+6,726
+16,815% +$19.9K ﹤0.01% 2101
2015
Q1
$0 Buy
+40
New ﹤0.01% 4698
2014
Q4
Sell
-9,552
Closed -$24K 4378
2014
Q3
$24K Buy
9,552
+7,257
+316% +$18.2K ﹤0.01% 2152
2014
Q2
$6K Sell
2,295
-542
-19% -$1.42K ﹤0.01% 2725
2014
Q1
$8K Buy
+2,837
New +$8K ﹤0.01% 2829